nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aims & Scope/ Editorial Board
|
|
|
2013 |
27 |
6 |
p. iii- 1 p. |
artikel |
2 |
Cost-effectiveness of Barrett's oesophagus screening and surveillance
|
Gordon, Louisa G. |
|
2013 |
27 |
6 |
p. 893-903 11 p. |
artikel |
3 |
Cost-effectiveness of biological agents used in ulcerative colitis
|
Lee, Jeannie K. |
|
2013 |
27 |
6 |
p. 949-960 12 p. |
artikel |
4 |
Cost-effectiveness of liver cancer screening
|
Cucchetti, Alessandro |
|
2013 |
27 |
6 |
p. 961-972 12 p. |
artikel |
5 |
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
|
Lansdorp-Vogelaar, Iris |
|
2013 |
27 |
6 |
p. 933-947 15 p. |
artikel |
6 |
Cost-effectiveness of viral hepatitis B & C treatment
|
Toy, Mehlika |
|
2013 |
27 |
6 |
p. 973-985 13 p. |
artikel |
7 |
Economic evaluation of colorectal cancer (CRC) screening
|
Cruzado, José |
|
2013 |
27 |
6 |
p. 867-880 14 p. |
artikel |
8 |
Functional disorders of the gastrointestinal tract: Cost effectiveness review
|
Mapel, Douglas W. |
|
2013 |
27 |
6 |
p. 913-931 19 p. |
artikel |
9 |
Generalizability of cost–utility analyses across countries and settings
|
Ginsberg, Gary M. |
|
2013 |
27 |
6 |
p. 845-852 8 p. |
artikel |
10 |
Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?
|
Goeree, Ron |
|
2013 |
27 |
6 |
p. 831-844 14 p. |
artikel |
11 |
Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies
|
Wang, Bruce C.M. |
|
2013 |
27 |
6 |
p. 987-995 9 p. |
artikel |
12 |
Second look endoscopy in acute non-variceal upper gastrointestinal bleeding
|
Chiu, Philip Wai Yan |
|
2013 |
27 |
6 |
p. 905-911 7 p. |
artikel |
13 |
The increasing need for health-economic assessment in gastrointestinal and liver diseases
|
Bardou, Marc |
|
2013 |
27 |
6 |
p. 829-830 2 p. |
artikel |
14 |
Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies
|
Bardou, Marc |
|
2013 |
27 |
6 |
p. 881-892 12 p. |
artikel |
15 |
What is the impact of disease prevalence upon health technology assessment?
|
Rotily, Michel |
|
2013 |
27 |
6 |
p. 853-865 13 p. |
artikel |